News | News By Subject | News by Disease News By Date | Search News

News By Date

Get Our FREE
Industry eNewsletter
email:    
News By Date

SuMoTuWeThFrSa
2829301234
567891011
12131415161718
19202122232425
2627282930311
2345678

Monday, July 06, 2015

Top Breaking News

News from Around the Web

Press Releases
Vertex (VRTX) Release: FDA Approves ORKAMBI (Lumacaftor/Ivacaftor) - The First Medicine To Treat The Underlying Cause Of Cystic Fibrosis For People Ages 12 And Older With Two Copies Of The F508del Mutation
Boehringer Ingelheim Release: Phase III Data Published In The Lancet Oncology Shows A Significant Overall Survival Benefit Of Giotrif (Afatinib) Compared To Tarceva(Erlotinib)
Versartis, Inc. (VSAR) Announces Removal Of FDA Partial Clinical Hold And Continuation Of VRS-317 Phase III Clinical Trial
Kamada Ltd. (KMDA) Announces Publication In Pediatric Diabetes
Celtaxsys, Inc. Gains FDA Clearance For Landmark Phase 2 Trial Of Anti-Inflammatory Treatment For Cystic Fibrosis (CF)
Akcea Therapeutics Receives Orphan Drug Designation From The US FDA For Volanesorsen (ISIS-APOCIII Rx) For The Treatment Of Familial Chylomicronemia Syndrome
Marinus Pharmaceuticals (MRNS) Release: Published Data Support Scientific Basis For Ganaxolone Use In PCDH19 Female Epilepsy
Array BioPharma, Inc. (ARRY) Release: Encorafenib-Based Regimens Show Promising Clinical Activity In BRAF-Mutant Colorectal Cancer Patients
Celsion Corporation (CLSN) Announces Continuing Positive Data From Its Phase 2 DIGNITY Study In Breast Cancer
ArQule, Inc. (ARQL) Announces Interim Phase II Study Results For Tivantinib In Combination With Cetuximab In Patients With MET-High, KRAS Wild Type Colorectal Cancer Presented At ESMO World Congress On Gastrointestinal Cancer 2015
Catabasis Pharmaceuticals, Inc. Receives FDA Fast Track Designation For CAT-1004 For The Treatment Of Duchenne Muscular Dystrophy
Alexion (ALXN) Release: Strensiq (asfotase alfa) Receives Marketing Approval In Japan For Treatment Of Patients With Hypophosphatasia (HPP)
Japan’s Ministry Of Health, Labour And Welfare Approves Gilead (GILD)’s Harvoni, The First Once-Daily Single Tablet Regimen For The Treatment Of Genotype 1 Chronic Hepatitis C
Evofem Submits New Drug Application To U.S. FDA For Amphora As A Contraceptive
RedHill Biopharma Ltd. (RDHL) Receives Authorization In Australia And New Zealand For Ongoing Phase III Crohn's Disease Study With RHB-104
XBiotech USA (XBIT) Treats First Patient In Phase I/II Clinical Study Of Novel True Human Therapeutic Antibody For Treating Serious Infections Due To Staphylococcus Aureus
PhytoTech Medical Ltd (ASX:PYL) Oral Formulations Advance Towards Phase 1 Clinical Trials
CEVEC Pharma's CAP(R)Go Derived Recombinant Placental Human Alkaline Phosphatase Shows Superior Results In A Preclinical Study
A*STAR Release: Singapore Team’s Discovery Of New Genomic Aberrations Of Gastric Cancer Could Pave The Way For Precision Medicine
Allergy Therapeutics plc Release: Positive Dust Mite Study Results
InVivo Therapeutics (NVIV) Reports Significant Improvement Of Second And Third Patients Implanted With Neuro-Spinal Scaffold
Avita Medical Data Demonstrating ReCell Effectiveness In Skin Repigmentation Published In Journal Of The American Academy Of Dermatology
BIOTRONIK Announces Start Of Pioneering BIOWOMEN Study
City of Hope Release: Salmonella Bacterium Could Prove Potent Foe To Aggressive Form Of Pancreatic Cancer
Millennium Healthcare, Inc. Signs Exclusive Letter Of Intent To Acquire HealthPath, LLC
Emdeon Corporation (HLTH) To Acquire Altegra Health
BioClinica, Inc. Acquires MediciGroup
China's Desano Pharma To Make New HIV Drug API For ViiV
ImmunoCellular Therapeutics, Ltd (IMUC) Establishes Agreement With Novella Clinical To Conduct ICT-107 Phase 3 Registration Trial In Glioblastoma
EUXmedia Announces Key Life Science Alliances
Multiple Myeloma Research Foundation (MMRF) Partners On Daratumumab Expanded Access Program (EAP) Now Open For Multiple Myeloma Patients
Auris Medical AG (EARS) Provides Update On U.S. Intellectual Property Portfolio
Anatara Lifesciences Raises $7 Million, Launches Share Purchase Plan To Speed Development Of Detach
Palatin Technologies (PTN) Completes $30 Million Financing
ESSA Pharma To Commence Trading On The NASDAQ Capital Market
NeuroDerm (NDRM) Files Registration Statement For Proposed Follow-On Offering
Janssen Biotech Inc. (JNJ) Release: Daratumumab Expanded Access Program Open To Eligible U.S. Patients With Heavily Pre-Treated Multiple Myeloma
TiGenix: Notice In Relation To The Convertible Bonds Due 2018
MediGene AG (MDGEF.PK): Medigene Announces Formal Closing Of Capital Measure
Spaulding Clinical Research Expands Clinical Pharmacology
Horizon Pharma (HZNP) Files Patent Infringement Lawsuits Against Five Companies For Filing Abbreviated New Drug Applications For PENNSAID(R) (Diclofenac Sodium Topical Solution) 2%
Federal Circuit Rules Against The Medicines Company (MDCO) In Angiomax (bivalirudin) Patent Litigation
BGI Receives Accreditation From The College of American Pathologists
Leica Microsystems Release: Brilliant Transmitted Light Imaging Due To Powerful Ultra-bright LEDs
Affymetrix (Santa Clara, California) (AFFX) To Report Second Quarter 2015 Operating Results On Wednesday July 29, 2015
Celgene (CELG) To Announce Second Quarter 2015 Results On July 23, 2015
Cerus (CERS) To Release Second Quarter 2015 Results On August 6, 2015
Darin Leigh Joins Metabolon As Chief Commercial Officer
Moerae Matrix, Inc. (Moerae) Appoints Bill Bradford, M.D., Phd, As Chief Medical Officer
Revance Therapeutics (RVNC) Announces Change In Role Of Jacob Waugh, M.D
Zogenix (ZGNX) Expands Senior Leadership Team To Further Drive Strategic Focus On CNS Disorders And Orphan Drug Development
LEO Pharma Announces New Vice President Of Sales
Vision RT Appoints Parth Amin As New VP, Strategic Alliances
Axxess Pharma, Inc. Hires Legal And Sales Veteran Michael Gelmon To Assist In Business Development And SEC Compliance
Delenex Therapeutics Extends Scientific Advisory Board
IMPAX Labs (IPXL) Announces Resignation Of Larry Hsu, Ph.D. From Board Of Directors
Andrew E. Sloan, MD Joins Pharmaco-Kinesis Corporation's Neuro-Oncology Clinical Advisory Board
Syros Pharmaceuticals Announces Appointment Of CEO Nancy Simonian To BIO Board
Tadataka Yamada, Ph.D., Former Head Of GlaxoSmithKline (GSK) And Takeda (TKPYY) R&D, Re-Joins Frazier Healthcare
VolitionRX Expands Scientific Advisory Board
2013 Tour De France Yellow Jersey Winner Chris Froome Appointed As Rhinomed's (ASX:RNO) Turbine Ambassador
Aegis Sciences Launches Fellowship Program With The Belmont University College Of Pharmacy
Theravance Biopharma Announces New Employment Inducement Awards
Teva (TEVA)'s DuoResp Spiromax Wins Leading Award For Medical Design Excellence
Nihon University To Host International Symposium On Medical-Engineering Collaboration
Biophotonic Solutions Inc. Founder To Present At Spectroscopic Imaging Workshop
Mologen AG (MOLGF.PK) Presented Poster At ESMO WCGI 2015
Navidea (NAVB) And Macrophage Therapeutics To Host Post-International KSHV Conference Summary Webcast
Ignyta (RXDX) To Present At Cantor Fitzgerald Healthcare Conference
BrainStorm Cell Therapeutics Inc. To Present At Cantor Fitzgerald's Inaugural Healthcare Conference
Applied Genetic Technologies Corporation President & CEO To Present At Cantor Healthcare Conference On July 8, 2015
Centene Corporation To Present At Cantor Fitzgerald Healthcare Conference
OncoMed Pharmaceuticals, Inc. (OMED) To Present At The Cantor Fitzgerald Inaugural Healthcare Conference
NewLink Genetics (NLNK) To Present At The Cantor Fitzgerald Healthcare Conference
Zogenix (ZGNX) To Participate In Cantor Fitzgerald Healthcare Conference
Week In Review: Zhongheng Pays $52 Million For Oramed (ORMP)'s Diabetes Drugs
China Halts IPOs In Move To Stop Stock Market Decline
Cambridge Medical Robotics Takes Aim at Intuitive Surgical (ISRG)
Medtronic (MDT) Sales Rep Killed in Random Shooting
Kubtec Announces FDA Approval of DIGIVIEW 395 High Resolution Wireless Flat Panel Detector
Mauna Kea Technologies Receives Regulatory Approval For The AQ-Flex 19 Miniprobe In Japan
Flower Orthopedics Cleared To Enter The European Union
Sirtex Medical (SRX.AX) Release: New SIRFLOX Study Data Presented At World Congress Of Gastrointestinal Cancer
Counsyl Adds Positive Predictive Value To Non-Invasive Pregnancy Screen Results Reports
Lima Corporate Announces Completion Of Zimmer (ZMH)-Biomet Inc. Assets Acquisition
Research Instruments Ltd Announces First European Patent For RI Witness System
BG Medicine (BGMD) Release: First Automated Test For Galectin-3 Now Available In U.S.
ECA Medical Instruments Develops Industry First Single-Procedure Ratchet To Reduce Time, Cut Cost Of Orthopaedic Implant Surgeries
OncoSec Medical Inc. To Ring The Nasdaq Stock Market Opening Bell
Zecotek Photonics Inc. Provides Corporate Update On 3D Technology Division
Enzo Biochem (ENZ) Reaches $7.1 Million Patent Infringement Settlement With Luminex (LMNX)
Cepheid (CPHD) Schedules 2015 Second Quarter Results Announcement And Webcast
Hologic (HOLX) To Announce Financial Results For The Third Quarter Of Fiscal 2015 On Wednesday, July 29, 2015
Merit Medical Systems, Inc. (MMSI) Announces Earnings Release Date/Time And Conference Call Information For The Second Quarter Ended June 30, 2015
ResMed (RMD) To Announce Fourth Quarter And Fiscal Year-End 2015 Results
OncoSec Medical Inc. Appoints Joann V. Lofgren As Vice President Of Market Development
India’s Refractive Surgery Society Awards Special Gold Medal To LENSAR CEO Nicholas T. Curtis
Biocept, Inc. (BIOC) Announces Panel Presentation At Cantor Fitzgerald Healthcare Conference

//-->